Search research articles
Contact Us
Filters
Showing results (161-170 of 206) with videos related to
Page
of 21
Sort By:
Prostate Cancer and Prostatic Diseases
|
November 2, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
B Benzon, S G Zhao, M C Haffner, et al.
The Journal of Clinical Investigation
|
April 1, 2026
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers
Alec Paschalis, Ines Figueiredo, Denisa Bogdan, et al.
European Urology Oncology
|
February 7, 2025
Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after <sup>177</sup>Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes
Ruben Raychaudhuri, Abuzar Moradi Tuchayi, Soon Khai Low, et al.
The American Journal of Pathology
|
March 27, 2018
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer
Michael C Haffner, Gunes Guner, Diana Taheri, et al.
Cancer Cell
|
November 3, 2023
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer
Jessica E Hawley, Aleksandar Z Obradovic, Matthew C Dallos, et al.
JCI Insight
|
December 8, 2021
Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer
Navonil De Sarkar, Sayan Dasgupta, Payel Chatterjee, et al.
JCI Insight
|
March 16, 2021
Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
W Nathaniel Brennen, Yezi Zhu, Ilsa M Coleman, et al.
Nature Cell Biology
|
August 17, 2023
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer
Leslie Duplaquet, Yixiang Li, Matthew A Booker, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
OGDHL regulates nucleotide metabolism, tumor growth, and neuroendocrine marker expression in prostate cancer
Matthew J Bernard, Angel Ruiz, Johnny A Diaz, et al.
The Journal of Clinical Investigation
|
June 15, 2021
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth
Michael D Nyquist, Lisa S Ang, Alexandra Corella, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 206) with videos related to
Sort By:
Page
of 21
Prostate Cancer and Prostatic Diseases
|
November 2, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
B Benzon, S G Zhao, M C Haffner, et al.
The Journal of Clinical Investigation
|
April 1, 2026
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers
Alec Paschalis, Ines Figueiredo, Denisa Bogdan, et al.
European Urology Oncology
|
February 7, 2025
Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after <sup>177</sup>Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes
Ruben Raychaudhuri, Abuzar Moradi Tuchayi, Soon Khai Low, et al.
The American Journal of Pathology
|
March 27, 2018
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer
Michael C Haffner, Gunes Guner, Diana Taheri, et al.
Cancer Cell
|
November 3, 2023
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer
Jessica E Hawley, Aleksandar Z Obradovic, Matthew C Dallos, et al.
JCI Insight
|
December 8, 2021
Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer
Navonil De Sarkar, Sayan Dasgupta, Payel Chatterjee, et al.
JCI Insight
|
March 16, 2021
Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
W Nathaniel Brennen, Yezi Zhu, Ilsa M Coleman, et al.
Nature Cell Biology
|
August 17, 2023
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer
Leslie Duplaquet, Yixiang Li, Matthew A Booker, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
OGDHL regulates nucleotide metabolism, tumor growth, and neuroendocrine marker expression in prostate cancer
Matthew J Bernard, Angel Ruiz, Johnny A Diaz, et al.
The Journal of Clinical Investigation
|
June 15, 2021
Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth
Michael D Nyquist, Lisa S Ang, Alexandra Corella, et al.
Page
of 21